Completion of Acquisition: RisoR Holdings B.V., Amsterdam, Netherlands, a wholly-owned step-down subsidiary of the Company, has completed the acquisition of Pendracare Holdings B.V. and Wellinq Medical B.V., Amsterdam, Netherlands ( PendraCare Group ).
POLYMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.2 pts more than Nifty Smallcap 250 and 2.8 pts more than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Poly Medicure Limited has completed the acquisition of the PendraCare Group — consisting of Pendracare Holdings B.V. and Wellinq Medical B.V., both based in Amsterdam, Netherlands. The deal was executed through its wholly-owned step-down Dutch subsidiary, RisoR Holdings B.V., after a Share Purchase Agreement was signed on September 23, 2025. Post-completion, Poly Medicure holds 90% of economic rights in the PendraCare Group, making both entities step-down subsidiaries of the company. The acquisition was first approved at the Board Meeting on September 3, 2025, and all conditions under the SPA have now been fulfilled.
This closes a key international acquisition, giving Poly Medicure a stronger foothold in the European medical devices market. While near-term integration costs may apply, shareholders can expect broader product reach and revenue diversification. The deal removes execution uncertainty and is a positive signal of the company's inorganic growth strategy.